Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 16, Issue 7, 2005, Pages 2052-2062

  Nagao, Shizuko ^a,b   Kusaka, Masatomo ^a   Nishii, Kazuhiro ^a   Marunouchi, Tohru ^a   Kurahashi, Hiroki ^a   Takahashi, Hisahide ^a   Grantham, Jared ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CYCLINE; FLUTAMIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAF PROTEIN; UREA; ANTIANDROGEN; B RAF KINASE; BRAF PROTEIN, RAT; PERK KINASE; PROTEIN KINASE R; TESTOSTERONE DERIVATIVE;

ANDROGEN DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASTRATION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; IMMUNOBLOTTING; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; METABOLISM; PATHOPHYSIOLOGY; SEX DIFFERENCE; SPRAGUE DAWLEY RAT;

ANDROGEN ANTAGONISTS; ANIMALS; CELL PROLIFERATION; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EIF-2 KINASE; FEMALE; FLUTAMIDE; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROTO-ONCOGENE PROTEINS B-RAF; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; SEX FACTORS; SIGNAL TRANSDUCTION; TESTOSTERONE CONGENERS;

EID: 27744513733     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004070595     Document Type: Article

References (40)

1. The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 881-894, 1994
2. The International Polycystic Kidney Disease Consortium: Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995
3. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996
4. Calvet JP, Grantham JJ: The genetics and physiology of polycystic kidney disease. Semin Nephrol 21: 107-123, 2001
5. Grantham J, Cowley BJ, Torres VE: Progression of autosomal dominant polycystic kidney disease (ADPKD) to renal failure. In: The Kidney: Physiology and Pathophysiology, Vol. 2, edited by Seldin D, Giebisch G, Philadelphia, Lippincott Williams & Wilkins, 2000, pp 2513-2536
6. Yamaguchi T, Felling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, Grantham JJ: cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57: 1460-1471, 2000
7. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED: EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64: 1573-1579, 2003
8. Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Felling JC, Grantham JJ: Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney M 63: 1983-1994, 2003
9. Hanaoka K, Guggino WB: cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11: 1179-1187, 2000
10. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41: 1311-1319, 1992
11. Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, Kaehny WD, Manco-Johnson M, Schrier RW: Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 38: 1177-1180, 1990
12. Grantham JJ: Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int Suppl 63: S93-S97, 1997
13. Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, Estivill X: Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 7: 2142-2151, 1996
14. Stewart JH: End-stage renal failure appears earlier in men than in women with polycystic kidney disease. Am J Kidney Dis 24: 181-183, 1994
15. Cowley BD Jr, Rupp JC, Muessel MJ, Gattone VH 2nd: Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. Am J Kidney Dis 29: 265-272, 1997
16. Nagao S, Yamaguchi T, Kusaka M, Maser RL, Takahashi H, Cowley BD, Grantham JJ: Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int 63: 427-437, 2003
17. Lynch CS, Story AJ: Dihydrotestosterone and estrogen regulation of rat brain androgen-receptor immunoreactivity. Physiol Behav 69: 445-453, 2000
18. Carmena MJ, Montalvo L, Solano RM, Clemente C, Roman ID, Sanchez-Chapado M, Prieto JC: Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostate. Cell Signal 12: 311-316, 2000
19. Baltatu O, Cayla C, Iliescu R: Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol 13: 2681-2687, 2002
20. Tanner GA, Gretz N, Connors BA, Evan AP, Steinhausen M: Role of obstruction in autosomal dominant polycystic kidney disease in rats. Kidney Int 50: 873-886, 1996
21. Ramasubbu K, Gretz N, Bachmann S: Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease. J Am Soc Nephrol 9: 937-945, 1998
22. Grantham JJ: 1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol 3: 1841-1857, 1993
23. Palmer BF: Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv Ren Replace Ther 10: 48-60, 2003
24. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 11: 319-329, 2000
25. Greene DM, Bondy GS, Azcona-Olivera JI, Pestka JJ: Role of gender and strain in vomitoxin-induced dysregulation of IgA production and IgA nephropathy in the mouse. J Toxicol Environ Health 43: 37-50, 1994
26. Ishikawa I, Maeda K, Nakai S, Kawaguchi Y: Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 35: 1072-1075, 2000
27. Sandberg K, JI H: Sex and the renin angiotensin system: Implications for gender differences in the progression of kidney disease. Adv Ren Replace Ther 10: 15-23, 2003
28. Pelletier G: Localization of androgen and estrogen receptors in rat and primate tissues. Histol Histopathol 15: 1261-1270, 2000
29. Sandhu S, Silbiger SR, Lei J, Neugarten J: Effects of sex hormones on fluid and solute transport in Madin-Darby canine kidney cells. Kidney Int 51: 1535-1539, 1997
30. Grantham JJ: Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: A systems biology approach. Kidney Int 64: 1157-1162, 2003
31. Sweeney WE Jr, Avner ED: Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 275: F387-F394, 1998
32. Pugh JL, Sweeney WE Jr, Avner ED: Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int 47: 774-781, 1995
33. Orellana SA, Sweeney WE, Neff CD, Avner ED: Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 47: 490-499, 1995
34. Parnell SC, Magenheimer BS, Maser RL, Zien CA, Frischauf AM, Calvet JP: Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J Biol Chem 277: 19566-19572, 2002
35. Parnell SC, Magenheimer BS, Maser RL, Rankin CA, Smine A, Okamoto T, Calvet JP: The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 251: 625-631, 1998
36. Belibi FA, Wallace DP, Yamaguchi T, Christensen M, Reif G, Grantham JJ: Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66: 1-10, 2004
37. Gattone VH 2nd, Maser RL, Tian C, Rosenberg JM, Branden MG: Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet 24: 309-318, 1999
38. Gattone VH 2nd, Wang X, Harris PC, Torres VE: Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9: 1323-1326, 2003
39. Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH 2nd: Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10: 363-364, 2004
40. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP: Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279: 40419-40430, 2004